| Date Filed | Type | Description |
| 03/21/2023 |
4
| Mayer Eldon C. III (Ex VP & Chief Commerc. Officer) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Sold 2,520 shares
@ $1.07, valued at
$2.7k
Sold 1,875 shares
@ $1.0707, valued at
$2k
|
|
| 03/03/2023 |
4
| Mayer Eldon C. III (Ex VP & Chief Commerc. Officer) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 98,000 options to buy
@ $1.705, valued at
$167.1k
|
|
| 01/30/2023 |
4
| Mayer Eldon C. III (Ex VP & Chief Commerc. Officer) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 31,500 options to buy
@ $1.37, valued at
$43.2k
|
|
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2022 |
4
| Mayer Eldon C. III (Ex VP & Chief Commerc. Officer) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Sold 1,560 shares
@ $4.9501, valued at
$7.7k
|
|
| 07/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2020 |
4
| Mayer Eldon C. III (Ex VP & Chief Commerc. Officer) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 7,500 shares
@ $0
Granted 150,000 options to buy
@ $12.36, valued at
$1.9M
|
|
| 01/30/2020 |
4
| Mayer Eldon C. III (Ex VP & Chief Commerc. Officer) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $13.5205, valued at
$67.6k
|
|
| 11/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2019 |
4
| Mayer Eldon C. III (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 10,000 options to buy
@ $13.41, valued at
$134.1k
|
|
| 03/22/2019 |
4
| Mayer Eldon C. III (EVP & Chief Commercial Officer) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 75,000 options to buy
@ $4.49, valued at
$336.8k
|
|
| 01/25/2019 |
4
| Mayer Eldon C. III (EVP & Chief Commercial Officer) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 200,000 options to buy
@ $2, valued at
$400k
|
|
| 11/30/2018 |
4
| Mayer Eldon C. III (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Bought 4,000 shares
@ $10.21, valued at
$40.8k
|
|
| 11/28/2018 |
4
| Mayer Eldon C. III (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Bought 7,500 shares
@ $9.7524, valued at
$73.1k
Bought 7,500 shares
@ $9.921, valued at
$74.4k
Bought 6,000 shares
@ $10.0745, valued at
$60.4k
|
|
| 09/12/2018 |
4
| Mayer Eldon C. III (EVP & Chief Commercial Officer) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Bought 50,000 shares
@ $3.2842, valued at
$164.2k
Bought 50,000 shares
@ $3.2268, valued at
$161.3k
|
|
| 08/27/2018 |
4
| Mayer Eldon C. III (EVP & Chief Commercial Officer) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Bought 100,000 shares
@ $2.8232, valued at
$282.3k
|
|
| 05/11/2018 |
4
| Mayer Eldon C. III (EVP & Chief Commercial Officer) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 50,000 options to buy
@ $2.11, valued at
$105.5k
|
|
| 03/16/2018 |
4
| Mayer Eldon C. III (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 10,000 options to buy
@ $9.5, valued at
$95k
|
|
| 01/26/2018 |
4
| Mayer Eldon C. III (EVP & Chief Commercial Officer) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 150,000 options to buy
@ $4.49, valued at
$673.5k
|
|
| 01/09/2018 |
4
| Mayer Eldon C. III (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $13.7, valued at
$342.5k
|
|
| 01/09/2018 |
3
| Mayer Eldon C. III (Director) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
| 02/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/11/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/11/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |